Article

Arkansas Online on 2021-12-21 09:08

Biogen cutting cost of Alzheimer's drug

Biogen is slashing the price of its Alzheimer's treatment in half months after it debuted to widespread criticism for an initial cost that could reach ...

Related news

Biogen cutting cost of Alzheimer's drug nwaonline.com
Japan , Cambridge
Biogen shares soar as FDA reviewers support Alzheimer's drug Sydney Morning Herald
Wall Street , Massachusetts , Cambridge
Biogen cuts the price tag on its Alzheimer's drug in half - Mon, 20 Dec 2021 PST apnews.com
Massachusetts , Cambridge , Japan
Change at the top for Biogen after Alzheimer's drug flops - Tue, 03 May 2022 PST apnews.com
Europe , Wall Street , Cambridge
MBiogen and Eisai make plans to take another Alzheimer's drug to the FDA3 min read marketwatch.com
Switzerland , Canton of Solothurn , Japan , San Francisco
WAlzheimer's drug from Biogen, partner receives FDA approval wraltechwire.com
Cambridge , Japan
Biogen reanalyzes studies, presses ahead on Alzheimer's drug lasvegassun.com
Indianapolis , Wall Street , Mayo Clinic , United States , Japan
Biogen tops 3Q expectations as cost cutting continues Seattle Times
Cambridge
FDA calls for investigation of Biogen Alzheimer's drug approval bizjournals.com
Biogen to cease production of controversial Alzheimer's drug POLITICO
MBiogen talks up approval plans for controversial Alzheimer's drug as it nears FDA decision marketwatch.com
Japan , Switzerland , Canada , Brazil , Australia
Biogen cuts the price for its Alzheimer’s drug in half pressherald.com
Massachusetts , Cambridge , Japan
Concerns grow over safety of Alzheimer's drug Aduhelm after death of patient who got the drug Star Tribune
Massachusetts , Cambridge , Canada
Biogen cuts the price tag on its Alzheimer’s drug in half journalrecord.com
Japan , Cambridge
HBiogen Cuts the Price Tag on its Alzheimer’s Drug in Half hamodia.com
Japan , Cambridge
BBiogen Searches for New CEO in Wake of Struggles With Alzheimer's Drug 4 min read barrons.com
BA Third Expert Quits FDA Panel Over Approval of Biogen Alzheimer's Drug 2 min barrons.com
MBiogen says it will pursue FDA approval of early Alzheimer's drug marketwatch.com
HU.S. Approval of Biogen Alzheimer’s Drug Sends Shares Soaring hamodia.com
Wall Street , Japan